Navidea Biopharmaceuticals Inc (NAVB)

[insideoutsideupside]

Umiak, a good post, but I'd temper your projections a bit. With partner revenue sharing, you can probably cut the revenue projection in half to $700M. Also the fully diluted share count is somewhere in the neighborhood of 150M. So the current market cap is aprox $450M on a fully diluted basis. Still undervalued and doesn't consider anything in the pipeline except LS.


On separate note, there are 8.3M warrants that expire in dec. With a conversion price of .46, Platinum should be giving Navidea approximately $4M in cash prior to the end of the year.